TMJ Fibrocartilage Detection Using MRI (WATS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03891511|
Recruitment Status : Recruiting
First Posted : March 27, 2019
Last Update Posted : March 27, 2019
|Condition or disease||Intervention/treatment|
|TMJ Disorders MRI Scans||Device: MRI scann|
|Study Type :||Observational|
|Estimated Enrollment :||59 participants|
|Official Title:||TMJ Fibrocartilage Detection Using 3D Fat-Suppressed Spoiled Gradient-Echo Magnetic Resonance Imaging|
|Actual Study Start Date :||March 18, 2019|
|Estimated Primary Completion Date :||April 30, 2019|
|Estimated Study Completion Date :||May 30, 2019|
- Device: MRI scann
MRI will be performed in the TMJ of participants affected with TMDOther Name: T1 WATS
- Presence of the TMJ Fibrocartilage layer [ Time Frame: six months ]The fibrocartilage layer will be evaluated dichotomously (absent/present) Patients will be examined using bilateral MRI (Phillips Intera 1,5 T, Sense Flex S Dual Coil) in the sagittal PD-weighted, T2-weighted and T1-weighted WATS, all in the oblique axis of the mandible condyle and with a closed mouth; dynamic gradient-echo at open mouth at 10 mm, 20 mm and 30 mm of the interincisal distance. Additionally, a coronal PD-weighted sequence with the mouth closed will be performed. Of each TMJ will be taken with 8×8 cm FOV and 0.2 cm spacing. All sequences will carried out using the same equipment and on the same day.
- Discontinuity of the TMJ FC layer [ Time Frame: six months ]The TMJ fibrocartilage layer will be evaluated dichotomously (continuous/discontinuous).
- Fibrocartilage Signal Intensity [ Time Frame: six month ]
Six regions of interest (ROIs) will be measured in the fibrocartilage layer of each TMJ. (anterior 0°, center 45° and posterior 90°), three in the mandibular condyle and three in the temporal fossa. The fibrocartilage signal intensity in each ROI will be expressed as the mean value of intensity units (Osirix).
All measurements will be made in a simple blinded system by four different observers (ML, MN, CV, GZ) (chi-square test for interobserver agreement: p˂0.05). Measurements will be made separately in the three MRI sequences (length tool, Osirix Imaging software). In all MRI sequences, TMJ will be magnified at a zoom of 3.6. For the T1 WATS sequence, the window width will be set at 90 intensity Units (IU) (all values above +90 Hounsfield Unit (HU) will be white), and the window level was 80 (IU) (all values below +80 HU will be black). All images will be measured and stored in DICOM format., lengt
- Thickness of the TMJ fibrocartilage layer [ Time Frame: Six months ]The TMJ FC thickness will be measured (curve tool, Osirix) and will expressed in millimeters.
- Length of the TMJ fibrocartilage layer [ Time Frame: Six moths ]The lenght of the TMJ FC layer will be measured (curve tool, Osirix) and will expressed in millimeters.
- Statistical analysis [ Time Frame: seven months ]
The Shapiro-Wilk test and Levene's test will be performed to assess normality of data distribution and homogeneity of variance of the measurements, respectively.
To determine the relationship between the presence or absence of fibrocartilage and the different sequences, Fisher's exact test will be used.
The thickness, length and signal intensity of the fibrocartilage layer will be expressed as a mean value, separated by MRI sequence, and will be analyzed using descriptive statistics.
SPSS v14.0 for Windows, statistical software will be used to perform data analysis.
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03891511
|Contact: Gustavo Moncada, PhDfirstname.lastname@example.org|
|Contact: Daniel Cortés, MS||+56 991233 email@example.com|
|San Vicente de Paul Centro de Diagnóstico||Recruiting|
|Santiago, Chile, 750005|
|Contact: Steffi Eckartd, MDS +562 2943 3900 firstname.lastname@example.org|
|Contact: Monica Bunster, BA +562 2943 3900 email@example.com|
|Principal Investigator: Gustavo Moncada, PhD|
|Sub-Investigator: Daniel Cortes, MS|
|Principal Investigator:||Gustavo Moncada, PhD||UAndes, Santiago, Chile|